Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-214321
Filing Date
2011-08-08
Accepted
2011-08-08 16:37:10
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 224989
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9190
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9190
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3239
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3239
  Complete submission text file 0001193125-11-214321.txt   1098166

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT appa-20110630.xml EX-101.INS 94746
7 XBRL TAXONOMY EXTENSION SCHEMA appa-20110630.xsd EX-101.SCH 10316
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appa-20110630_cal.xml EX-101.CAL 25426
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appa-20110630_def.xml EX-101.DEF 6842
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE appa-20110630_lab.xml EX-101.LAB 68236
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appa-20110630_pre.xml EX-101.PRE 63726
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 111017586
SIC: 2834 Pharmaceutical Preparations